<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04974710</url>
  </required_header>
  <id_info>
    <org_study_id>20/WS/0111</org_study_id>
    <nct_id>NCT04974710</nct_id>
  </id_info>
  <brief_title>Developing an US-MRI Biomarker Fusion Model for Endometriosis</brief_title>
  <acronym>DEFEND</acronym>
  <official_title>Developing an US-MRI Biomarker Fusion Model for Endometriosis (DEFEND)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Perspectum</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>GE Healthcare</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Perspectum</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Single centre, prospective, observational, cohort study looking to develop a database&#xD;
      representing the variability of disease and imaging seen in women with clinically diagnosed&#xD;
      endometriosis, awaiting laparoscopic surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In the United Kingdom (UK), endometriosis is one of the most common gynaecological diseases&#xD;
      needing treatment. The prevalence of disease is often underestimated, however it is believed&#xD;
      to affect at least 1 in 10 women in the UK. Within the NHS, endometriosis costs the UK&#xD;
      economy approximately Â£8.2 billion a year in treatment, loss of work and healthcare costs.&#xD;
&#xD;
      Currently, the first diagnostic recommendation for endometriosis is and Ultrasound (US) scan&#xD;
      or a MRI, followed by a diagnostic surgery called laparoscopy. Accurate diagnoses is usually&#xD;
      limited to specialist tertiary centres, therefore a delayed diagnosis is a significant&#xD;
      problem for women with endometriosis. Limited experience in the disease area can also lead to&#xD;
      misdiagnosis and the latest report from the National Institute of Clinical Excellence (NICE)&#xD;
      reports a time delay of around 7.5 years before a confirmed diagnosis of endometriosis. A&#xD;
      model that could accurately predict surgical findings of endometriosis would be of&#xD;
      significant clinical and economical benefit.&#xD;
&#xD;
      The main aim of this study is to curate a database of patients with varying levels of&#xD;
      endometriosis. This database will contain fully anonymised MR and US images alongside&#xD;
      clinical data for further use in research. There will be no intervention outside of standard&#xD;
      of care. US and clinical data will be collected during routine visits and patients will be&#xD;
      offered an additional visit to have a MRI. The ultimate aim is to then use this data to&#xD;
      develop a widely available diagnostic tool based on MRI and US imaging modalities using&#xD;
      computer modelling. Validating the predictive model with surgical findings will increase&#xD;
      confidence and access to advanced imaging for non-experts, allowing clinicians to accurately&#xD;
      predict surgical findings as well as reduce time to diagnosis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 2021</start_date>
  <completion_date type="Anticipated">July 2023</completion_date>
  <primary_completion_date type="Anticipated">July 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Build a database of 100 patients with endometriosis, awaiting confirmatory laparoscopic surgery on to an anonymised database for future use in algorithm development.</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluate inter-observer variability in diagnosing and staging endometriosis using both two and three dimensional ultrasound by computing inter-rater agreement statistics (e.g. Kappa statistic)</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assess the utility multi-parametric MRI in diagnosing and staging endometriosis</measure>
    <time_frame>12 months</time_frame>
    <description>Using measurements such as cT1, PDFF and Diffusion Weighted Imaging (DWI) to the MR imaging variables with a clinical diagnosis.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Endometriosis</condition>
  <condition>Reproductive System Disorder</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Outpatient MRI</intervention_name>
    <description>All participants will undergo a standardised imaging protocol in a MRI scanner. This will take place during the same visit or following the transvaginal ultrasound (TVUS) and in advance of any surgical procedure (laparoscopy).</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Women with clinically diagnosed endometriosis and awaiting laparoscopic surgery&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Women aged between 18-40 years&#xD;
&#xD;
          -  Clinically diagnosed endometriosis and awaiting surgery&#xD;
&#xD;
          -  BMI 20-35 kg/m2&#xD;
&#xD;
          -  No past abdominal surgical history&#xD;
&#xD;
          -  Participant willing and able to give informed consent for participation in the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Previous surgery in 12 months prior to consent:&#xD;
&#xD;
               -  abdominal surgery&#xD;
&#xD;
               -  surgery for endometriosis&#xD;
&#xD;
          -  The participant may not enter the study if they have any contraindication to magnetic&#xD;
             resonance imaging (standard MR exclusion criteria including pregnancy, extensive&#xD;
             tattoos, pacemaker, shrapnel injury, severe claustrophobia).&#xD;
&#xD;
          -  Any other cause, including a significant disease or disorder which, in the opinion of&#xD;
             the investigator, may either put the participant at risk because of participation in&#xD;
             the study, or may influence the participant's ability to participate in the study.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ippokratis Sarris, BM, BCh</last_name>
    <role>Principal Investigator</role>
    <affiliation>King's Fertility</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gemma Greenall, BSc</last_name>
    <phone>01865655343</phone>
    <email>DEFEND@perspectum.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>King's Fertility</name>
      <address>
        <city>London</city>
        <zip>SE5 8BB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <contact>
      <last_name>Laura Ismail, BSc, MRCOG</last_name>
      <phone>02039577950</phone>
      <email>Laura.Ismail@kingsfertility.co.uk</email>
    </contact>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <reference>
    <citation>Bulun SE, Yilmaz BD, Sison C, Miyazaki K, Bernardi L, Liu S, Kohlmeier A, Yin P, Milad M, Wei J. Endometriosis. Endocr Rev. 2019 Aug 1;40(4):1048-1079. doi: 10.1210/er.2018-00242. Review.</citation>
    <PMID>30994890</PMID>
  </reference>
  <reference>
    <citation>Bondza PK, Maheux R, Akoum A. Insights into endometriosis-associated endometrial dysfunctions: a review. Front Biosci (Elite Ed). 2009 Jun 1;1:415-28. Review.</citation>
    <PMID>19482656</PMID>
  </reference>
  <reference>
    <citation>Johnson NP, Hummelshoj L, Adamson GD, Keckstein J, Taylor HS, Abrao MS, Bush D, Kiesel L, Tamimi R, Sharpe-Timms KL, Rombauts L, Giudice LC; World Endometriosis Society Sao Paulo Consortium . World Endometriosis Society consensus on the classification of endometriosis. Hum Reprod. 2017 Feb;32(2):315-324. doi: 10.1093/humrep/dew293. Epub 2016 Dec 5.</citation>
    <PMID>27920089</PMID>
  </reference>
  <reference>
    <citation>Heilier JF, Donnez J, Nackers F, Rousseau R, Verougstraete V, Rosenkranz K, Donnez O, Grandjean F, Lison D, Tonglet R. Environmental and host-associated risk factors in endometriosis and deep endometriotic nodules: a matched case-control study. Environ Res. 2007 Jan;103(1):121-9. Epub 2006 Jun 15.</citation>
    <PMID>16781705</PMID>
  </reference>
  <reference>
    <citation>Koninckx PR, Martin DC. Deep endometriosis: a consequence of infiltration or retraction or possibly adenomyosis externa? Fertil Steril. 1992 Nov;58(5):924-8.</citation>
    <PMID>1426377</PMID>
  </reference>
  <reference>
    <citation>Ferrero S, Alessandri F, Racca A, Leone Roberti Maggiore U. Treatment of pain associated with deep endometriosis: alternatives and evidence. Fertil Steril. 2015 Oct;104(4):771-792. doi: 10.1016/j.fertnstert.2015.08.031. Epub 2015 Sep 10. Review.</citation>
    <PMID>26363387</PMID>
  </reference>
  <reference>
    <citation>Leyland N, Casper R, Laberge P, Singh SS; SOGC. Endometriosis: diagnosis and management. J Obstet Gynaecol Can. 2010 Jul;32(7 Suppl 2):S1-32.</citation>
    <PMID>21545757</PMID>
  </reference>
  <reference>
    <citation>Berger J, Henneman O, Rhemrev J, Smeets M, Jansen FW. MRI-Ultrasound Fusion Imaging for Diagnosis of Deep Infiltrating Endometriosis - A Critical Appraisal. Ultrasound Int Open. 2018 Sep;4(3):E85-E90. doi: 10.1055/a-0647-1575. Epub 2018 Sep 24.</citation>
    <PMID>30255164</PMID>
  </reference>
  <reference>
    <citation>Bazot M, Thomassin I, Hourani R, Cortez A, Darai E. Diagnostic accuracy of transvaginal sonography for deep pelvic endometriosis. Ultrasound Obstet Gynecol. 2004 Aug;24(2):180-5.</citation>
    <PMID>15287057</PMID>
  </reference>
  <reference>
    <citation>Slack A, Child T, Lindsey I, Kennedy S, Cunningham C, Mortensen N, Koninckx P, McVeigh E. Urological and colorectal complications following surgery for rectovaginal endometriosis. BJOG. 2007 Oct;114(10):1278-82.</citation>
    <PMID>17877680</PMID>
  </reference>
  <reference>
    <citation>Padavala J, Navaneetham N. Complications after surgery for deeply infiltrating pelvic endometriosis. BJOG. 2011 Dec;118(13):1678; author reply 1678-9. doi: 10.1111/j.1471-0528.2011.03162.x.</citation>
    <PMID>22077260</PMID>
  </reference>
  <reference>
    <citation>Nezhat C, Li A, Falik R, Copeland D, Razavi G, Shakib A, Mihailide C, Bamford H, DiFrancesco L, Tazuke S, Ghanouni P, Rivas H, Nezhat A, Nezhat C, Nezhat F. Bowel endometriosis: diagnosis and management. Am J Obstet Gynecol. 2018 Jun;218(6):549-562. doi: 10.1016/j.ajog.2017.09.023. Epub 2017 Oct 13. Review.</citation>
    <PMID>29032051</PMID>
  </reference>
  <reference>
    <citation>Rosefort A, Huchon C, Estrade S, Paternostre A, Bernard JP, Fauconnier A. Is training sufficient for ultrasound operators to diagnose deep infiltrating endometriosis and bowel involvement by transvaginal ultrasound? J Gynecol Obstet Hum Reprod. 2019 Feb;48(2):109-114. doi: 10.1016/j.jogoh.2018.04.004. Epub 2018 Apr 11.</citation>
    <PMID>29654939</PMID>
  </reference>
  <reference>
    <citation>Creed JM, Maggrah A, Usher R, Desa E, Harbottle A. How can mitochondrial DNA deletions act as a biomarker for the detection of endometriosis within the clinic? Biomark Med. 2020 Jan;14(1):5-8. doi: 10.2217/bmm-2019-0435. Epub 2019 Nov 5.</citation>
    <PMID>31686548</PMID>
  </reference>
  <reference>
    <citation>Viera AJ, Garrett JM. Understanding interobserver agreement: the kappa statistic. Fam Med. 2005 May;37(5):360-3.</citation>
    <PMID>15883903</PMID>
  </reference>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>June 11, 2021</study_first_submitted>
  <study_first_submitted_qc>July 13, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 23, 2021</study_first_posted>
  <last_update_submitted>August 3, 2021</last_update_submitted>
  <last_update_submitted_qc>August 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Reproductive health</keyword>
  <keyword>Diagnostics</keyword>
  <keyword>Magnetic Resonance Imaging</keyword>
  <keyword>Ultrasound</keyword>
  <keyword>Biomarkers</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Endometriosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No individual participant will be identified.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

